NasdaqCM - Nasdaq Real Time Price • USD
Acurx Pharmaceuticals, Inc. (ACXP)
At close: April 25 at 4:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DELUCCIA ROBERT J Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jan 3, 2024 | 964,782 |
| LUCI DAVID P Chief Executive Officer | Conversion of Exercise of derivative security | Jan 3, 2024 | 1,098,280 |
| SAILER CARL Director | Conversion of Exercise of derivative security | Jan 19, 2024 | 117,552 |
Related Tickers
NGENF NervGen Pharma Corp.
1.5000
-1.96%
MDNAF Medicenna Therapeutics Corp.
1.4000
+0.72%
NYMXF Nymox Pharmaceutical Corporation
0.3000
-6.25%
CMPX Compass Therapeutics, Inc.
1.4800
0.00%
CAPR Capricor Therapeutics, Inc.
5.15
+2.18%
ZURA Zura Bio Limited
3.6200
+9.37%
LUMO Lumos Pharma, Inc.
2.7600
-2.13%
BNOX Bionomics Limited
0.9663
+1.72%
NGEN.V NervGen Pharma Corp.
2.0200
-3.35%
ARTL Artelo Biosciences, Inc.
1.3400
+1.52%